Paolo Fundaro

Track

Insider profile

Currently holds a position at Intercept Pharmaceuticals Inc

Performance

Overall performance
3.8
Performance over holding periods
3.8
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Chairman of the Board Intercept Pharmaceuticals Inc Oct. 1, 2015 -
Independent Director Intercept Pharmaceuticals Inc Jan. 1, 2006 - Oct. 1, 2015
Paolo Fundaro's trades of Intercept Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-17 2020-08-17
S Sale
81,087 -42.9%
244.95
US$3,555,572 		81,087 -42.9% 244.95 US$3,555,572
2020-08-17 2020-08-17
S Sale
12,182 -34.3%
165.15
US$2,164,740 		12,182 -34.3% 165.15 US$2,164,740
2020-08-17 2020-08-14
S Sale
91,960 +36.1%
148.42
US$239,904 		91,960 +36.1% 148.42 US$239,904
2020-08-17 2020-08-13
S Sale
83,000 -1.5%
52.60
US$4,365,451 		83,000 -1.5% 52.60 US$4,365,451
2020-05-15 2020-05-13
S Sale
595,578 -9.8%
84.60
US$50,385,899 		595,578 -9.8% 84.60 US$50,385,899
2019-03-29 2019-03-29
PlS Planned sale
2,171 -16.3%
107.45
US$233,272 		2,171 -16.3% 107.45 US$233,272